lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
338 rows where filing_period = "second_quarter", filing_year = 2020 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: income_amount, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2460493 | ATLAS ADVOCACY d8e031b5-0ff6-41b6-bb48-24b7f767ba1f | Q2 | ATLAS ADVOCACY | 401100069 | BLADDER CANCER ADVOCACY NETWORK | 2020 | second_quarter | MED | CDMRP; Disease Awreness resolution | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 0 | 2020-06-30T17:47:33.907000-04:00 | |
| 2460551 | FRANCIS EDWARD & CRONIN, INC. fc55f948-2c7a-4858-bea5-8c3328c308a8 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2020 | second_quarter | MED | Issues and legislation related to Alzheimer's disease research | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2020-07-01T09:24:56.350000-04:00 | |
| 2460554 | FRANCIS EDWARD & CRONIN, INC. 14d31ff7-3a95-46a0-8c15-96f518926e6a | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2020 | second_quarter | MED | Issues and legislation related to diabetes treatment and diagnosis | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-01T09:28:57.497000-04:00 | ||
| 2460589 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) dcbda974-40a7-47bc-9cf9-007552cec98c | Q2 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | PPLA | 2020 | second_quarter | MED | Pharmaceutical labeling | Food & Drug Administration (FDA) | 18700 | 0 | 0 | 2020-07-01T11:00:10.853000-04:00 | |
| 2460629 | OTT BIELITZKI & O'NEILL PLLC 25ddcbe8-78f9-4e22-a459-6f2ae6de4584 | Q2 | OTT BIELITZKI & O'NEILL PLLC | 401103584 | BIOPORTO DIAGNOSTICS A/S | 2020 | second_quarter | MED | Educating officials about a health care diagnostic tool. | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2020-07-01T13:15:27.487000-04:00 | |
| 2460948 | BALLARD PARTNERS a113613d-0485-4f6a-8d13-d77cc3f0dd74 | Q2 | BALLARD PARTNERS | 401104288 | ORIGIN LOGISTICS, LLC | 2020 | second_quarter | MED | Issues related to diagnostic testing for COVID-19. | Health & Human Services, Dept of (HHS) | 40000 | 0 | 0 | 2020-07-02T17:29:34.363000-04:00 | |
| 2461070 | MARSHALL BRACHMAN f17498ae-9e5b-48c3-8b3f-92b59868149d | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2020 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2020-07-03T11:59:32.487000-04:00 | |
| 2461404 | ISEMAN & ASSOCIATES LLC bf3759e8-2a87-4dc6-91d2-a99e667e0f1d | Q2 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2020 | second_quarter | MED | Monitoring biotech legislation | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2020-07-06T14:03:24.150000-04:00 | |
| 2461453 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) adfa0837-e0db-424b-b4b4-56933b6e3227 | Q2 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 400265214 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 2020 | second_quarter | MED | Funding for COVID treatments and research Funding of federally-sponsored research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research H.R. 3038, "Securing American Science and Technology Act" - provisions related to establishing a system for addressing concerns about foreign influence on research | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2020-07-06T15:00:20.730000-04:00 | |
| 2461457 | RUSSELL PUBLIC COMMUNICATIONS 2c27239c-ccdc-418f-9b05-426b193bd3b2 | Q2 | RUSSELL PUBLIC COMMUNICATIONS | 401104398 | DIGITAL PATHOLOGY ASSOCIATION | 2020 | second_quarter | MED | Urge CMS waiver, in view of pandemic response, to permit remote digital pathology sign-offs | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,White House Office | 10000 | 0 | 0 | 2020-07-06T15:13:50.277000-04:00 | |
| 2461517 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 868d4579-8f39-4f7b-a7c8-845e4a6e23f5 | 2A | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 400265214 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 2020 | second_quarter | MED | Funding for COVID treatments and research Funding of federally-sponsored research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research H.R. 3038, "Securing American Science and Technology Act" - provisions related to establishing a system for addressing concerns about foreign influence on research | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2020-07-06T18:00:28.370000-04:00 | |
| 2461530 | THE PETRIZZO GROUP, INC. 651d65d3-4789-4a9f-b940-3ef976fe8e31 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ACCESS TO ADVANCED HEALTH INSTITUTE | 2020 | second_quarter | MED | Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; support adjuvant inclusion in COVID-19 countermeasures. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2020-07-06T19:40:28.183000-04:00 | |
| 2461554 | MUNK POLICY & LAW 61c61d87-0787-4eec-9f92-43dac4190662 | Q2 | MUNK POLICY & LAW | 401105075 | SOUTHERN METHODIST UNIVERSITY | 2020 | second_quarter | MED | Traumatic Brain Injury Research | HOUSE OF REPRESENTATIVES,SENATE,U.S. Geological Survey (USGS) | 30000 | 0 | 0 | 2020-07-06T22:48:42.217000-04:00 | |
| 2461627 | AMERICAN COLLEGE OF CLINICAL PHARMACY 370193c2-281b-4443-827d-007bdb2d6238 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2020 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2020-07-07T04:42:14.807000-04:00 | |
| 2461734 | WATKINS & EAGER PLLC 002629c7-839c-4898-a714-38b45e762876 | Q2 | WATKINS & EAGER PLLC | 401104403 | NATIONAL FRAGILE X FOUNDATION | 2020 | second_quarter | MED | Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2020-07-07T12:00:23.510000-04:00 | |
| 2461794 | CONGRESSIONAL SOLUTIONS, INC (CSI) 0dff3624-1084-4393-9995-6ca95f402ae5 | Q2 | CONGRESSIONAL SOLUTIONS, INC (CSI) | 297237 | UNIVERSITY OF NORTH TEXAS SYSTEM | 2020 | second_quarter | MED | COVID19 Research | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2020-07-07T13:20:58.287000-04:00 | |
| 2461850 | BLUEBIRD STRATEGIES 32ee8af9-48fb-44d7-83fe-7dd10ef03fae | Q2 | BLUEBIRD STRATEGIES | 401105447 | MYRIAD GENETICS, INC. | 2020 | second_quarter | MED | Legislation to regulate clinical labs under CLIA and FDA. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-07T14:13:34.257000-04:00 | |
| 2461854 | BLUEBIRD STRATEGIES fb598e50-07a4-4122-9334-2b2e1eb73d02 | Q2 | BLUEBIRD STRATEGIES | 401105447 | MYOTONIC | 2020 | second_quarter | MED | Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-07T14:15:38.380000-04:00 | |
| 2461977 | AUBURN HEALTH STRATEGIES, LLC 2d7472b9-8107-4f6e-ae3b-419160d9a9c5 | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | NEUROTECH, LLC | 2020 | second_quarter | MED | EEG monitoring | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-07T15:40:06.220000-04:00 | ||
| 2462070 | SQUIRE PATTON BOGGS 63a45a46-548e-4850-a950-07cc0f11b188 | Q2 | SQUIRE PATTON BOGGS | 30906 | LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. | 2020 | second_quarter | MED | Funding support for federally qualified health centers; reauthorization of programs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-07T16:25:04.657000-04:00 | |
| 2462510 | WINNING STRATEGIES WASHINGTON b29daada-d5c5-4cf4-bd5c-94626beef28b | 2T | WINNING STRATEGIES WASHINGTON | 50796 | RISING PHARMA HOLDINGS, INC. | 2020 | second_quarter | MED | Distribution of generic pharmaceutical products | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2020-07-08T14:18:22.133000-04:00 | |
| 2462612 | THE CORMAC GROUP, LLC f063f5f7-85e8-4c3f-9876-dbf78ddcccb3 | Q2 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2020 | second_quarter | MED | Appropriations, DOD, TBI research, Veterans Issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-08T17:20:33.833000-04:00 | |
| 2462759 | BEN BARNES GROUP LP 3b3bc387-59c3-4806-8797-66053ee41d6a | 2A | BEN BARNES GROUP LP | 5415 | ENVIGO RMS LLC | 2020 | second_quarter | MED | Medical/Disease Research | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-09T10:12:12.623000-04:00 | |
| 2462825 | SQUIRE PATTON BOGGS 8480ae8e-18ff-4626-97e7-81e06960282e | Q2 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2020 | second_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2020-07-09T11:24:54.103000-04:00 | |
| 2462943 | THE LIVINGSTON GROUP, LLC e61f3968-44e1-4c53-8967-6db6eed3a060 | 2T | THE LIVINGSTON GROUP, LLC | 49635 | 50 CITIES INC | 2020 | second_quarter | MED | Infectious disease prevention. | 20000 | 0 | 1 | 2020-07-09T13:03:36.403000-04:00 | ||
| 2462985 | FEDERAL SOLUTIONS, LLC 921dfe17-d940-4c9c-8035-afc3f1fdca0c | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2020 | second_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2020-07-09T13:28:10.947000-04:00 | |
| 2463035 | KUTAK ROCK LLP 77cb75d0-b5e1-450d-8852-2da0713e79a0 | Q2 | KUTAK ROCK LLP | 21962 | NE ENTERPRISES | 2020 | second_quarter | MED | Reauthorization of Pandemic and All Hazards Preparedness Act and related matters | 10000 | 0 | 0 | 2020-07-09T14:00:51.290000-04:00 | ||
| 2463051 | THE PETRIZZO GROUP, INC. 8ec0426b-98a3-4f8a-b238-8906549e6971 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | CEL-SCI CORPORATION | 2020 | second_quarter | MED | Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19 | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S. | 50000 | 0 | 0 | 2020-07-09T14:41:12.077000-04:00 | |
| 2463062 | THE PETRIZZO GROUP, INC. 92e2601e-399b-4e3f-a81d-0f1eb07c4261 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2020 | second_quarter | MED | Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2020-07-09T14:49:19.820000-04:00 | |
| 2463064 | THE PETRIZZO GROUP, INC. 16060eb3-de11-4e0d-9051-09f01ca3f249 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2020 | second_quarter | MED | Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. The Human Projectome Project, a comprehensive Atlas of cell types in human brain and the Mouse Connectome Project for BRAIN Initiative | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2020-07-09T14:52:21.003000-04:00 | |
| 2463127 | RAY C CULVER III f2edc2d2-21ae-4ec1-845e-68b0ef3b4dd1 | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2020 | second_quarter | MED | Funding for USDA ARS Human Nutrition Research Centers in the FY2021 House and Senate Agricultural Appropriations bills and finalizing funding for FY20 | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2020-07-09T21:37:10.690000-04:00 | |
| 2463157 | SQUIRE PATTON BOGGS 51f5e857-434c-454c-ab3b-d76c9956c234 | Q2 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2020 | second_quarter | MED | National Library of Medicine indexing matters. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2020-07-10T09:42:41.437000-04:00 | |
| 2463180 | SQUIRE PATTON BOGGS 89fcf09b-e82f-499e-a6a4-8fc3f4fb6d1b | Q2 | SQUIRE PATTON BOGGS | 30906 | NATIONAL CANNABIS ROUNDTABLE | 2020 | second_quarter | MED | Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. | HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of,White House Office | 80000 | 0 | 0 | 2020-07-10T09:47:56.033000-04:00 | |
| 2463256 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH ecbcd839-d274-42fd-a682-8cfab07bac11 | Q2 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2020 | second_quarter | MED | Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 69560 | 0 | 0 | 2020-07-10T10:58:58.117000-04:00 | |
| 2463341 | GOLDBUG STRATEGIES LLC 8f495fe9-5e7d-4eb9-ba1d-797fa3f1d086 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | COALITION FOR 21ST CENTURY MEDICINE | 2020 | second_quarter | MED | in vitro diagnostics, clinical laboratories, digital health regulation | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 19000 | 0 | 0 | 2020-07-10T12:04:39.177000-04:00 | |
| 2463439 | THE JACKSON LABORATORY 5019f127-520a-4e2d-a3b4-4f23a4a28190 | Q2 | THE JACKSON LABORATORY | 401104723 | THE JACKSON LABORATORY | 2020 | second_quarter | MED | Issues pertaining to basic science research and biomedical research. The background and use of animal models in biomedical research. National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations. Issues pertaining to COVID-19 diagnosis and animal model discovery. | HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) | 30000 | 0 | 0 | 2020-07-10T13:43:06.773000-04:00 | |
| 2463765 | REPUBLIC CONSULTING, LLC e08a0d9b-0096-4f30-9d8f-f3969077cd59 | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2020 | second_quarter | MED | Monitor Data and Science policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2020-07-11T12:50:40.997000-04:00 | |
| 2463843 | THE PETRIZZO GROUP, INC. 363005e6-8129-45db-87ff-98b0f746fe17 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2020 | second_quarter | MED | Funding for NIH research; H.R. 4159, PACT Act. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2020-07-12T14:54:54.687000-04:00 | |
| 2464141 | WAKE FOREST UNIVERSITY HEALTH SCIENCES a637eea8-e326-4684-bdff-554c02a23742 | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2020 | second_quarter | MED | FY21 Department of Labor/HHS Appropriations bill | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2020-07-13T12:41:58.370000-04:00 | |
| 2464370 | STANFORD UNIVERSITY 0666268d-579e-4077-b8c5-7437ea0b16d9 | Q2 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2020 | second_quarter | MED | HR748 Coronavirus Aid Relief and Economic Security Act of 2020 HR6800 Health and Economic Recovery Omnibus Emergency Solutions Act Reciprocity of Licensing Standards for Health Care Practitioners and Professionals Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs | Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS) | 90000 | 0 | 0 | 2020-07-13T15:35:54.017000-04:00 | |
| 2464703 | AMERICAN PHYSICAL THERAPY ASSOCIATION 209c5d88-63c3-47fb-99be-296b69210e1f | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2020 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention HR 7154 Outpatient Therapy Modernization and Stabilization Act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office | 236490 | 0 | 0 | 2020-07-14T09:37:31.037000-04:00 | |
| 2464735 | AMERICAN PHYSICAL THERAPY ASSOCIATION 413c57ce-e409-4d68-a212-11f20aeaabbc | 2A | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2020 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention HR 7154 Outpatient Therapy Modernization and Stabilization Act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office | 236490 | 0 | 0 | 2020-07-14T09:53:36.907000-04:00 | |
| 2464794 | MARSHFIELD CLINIC HEALTH SYSTEM 79b2f996-652d-46ab-9481-f4310d42cd27 | Q2 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2020 | second_quarter | MED | General research support, health care quality improvement, precision medicine | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2020-07-14T10:46:53.967000-04:00 | |
| 2464879 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 218f2d1b-8736-4a99-aac6-4e674989b80f | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2020 | second_quarter | MED | NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues, pediatric research bill HR4519 PACT Act, COVID related testing and research | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40560 | 0 | 0 | 2020-07-14T11:37:14.437000-04:00 | |
| 2465144 | TODD STRATEGY GROUP 9ea8a8ed-5dd1-49d9-8cf2-ce7fcfc57d01 | Q2 | TODD STRATEGY GROUP | 401103321 | BIODESIX, INC. | 2020 | second_quarter | MED | FDA regulation of laboratory developed tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-14T14:10:29.973000-04:00 | |
| 2465276 | K&L GATES, LLP 3165eda5-f6d9-4270-b2e5-e995db447e89 | Q2 | K&L GATES, LLP | 32098 | NATIONAL ASSN FOR BIOMEDICAL RESEARCH | 2020 | second_quarter | MED | Issues related to medical research (no legislation). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Transportation, Dept of (DOT) | 20000 | 0 | 0 | 2020-07-14T14:59:19.093000-04:00 | |
| 2465294 | TODD STRATEGY GROUP c05f8afd-2ed8-4351-be78-3812bde95964 | Q2 | TODD STRATEGY GROUP | 401103321 | ORGANIZE.ORG | 2020 | second_quarter | MED | Organ procurement policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-14T15:03:24.087000-04:00 | |
| 2465766 | MCDERMOTT+ LLC 90294512-29fc-429d-bc5f-420e7ec88e6e | Q2 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2020 | second_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2020-07-15T10:08:42.967000-04:00 | |
| 2465844 | WINNING STRATEGIES WASHINGTON 4bbbf2ef-ff4e-4d44-9970-248325ccbeee | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | I AM ALS | 2020 | second_quarter | MED | Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2020-07-15T10:47:05.550000-04:00 | |
| 2465999 | WINNING STRATEGIES WASHINGTON 30459796-566c-45e2-9f4e-91806b47f7a6 | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | PHLOW CORPORATION | 2020 | second_quarter | MED | Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-15T11:17:36.900000-04:00 | |
| 2466007 | THE PRENDA GROUP LLC 6ab5aa4b-b018-4235-83fa-4ffe4ba48478 | Q2 | THE PRENDA GROUP LLC | 401104543 | UV-CONCEPTS | 2020 | second_quarter | MED | Emergency response to COVID-19 Pandemic. Assistance to Hospitals / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. CARES ACT HR 748 S 3548 | HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 10000 | 0 | 0 | 2020-07-15T11:18:26-04:00 | |
| 2466179 | WINNING STRATEGIES WASHINGTON bdf8683d-9d11-4dea-a9b9-4b3f595ce17c | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | RETRACTABLE TECHNOLOGIES INC (RTI) | 2020 | second_quarter | MED | Response to COVID-19 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-15T12:03:04.730000-04:00 | |
| 2466467 | COMMONWEALTH POLICY SOLUTIONS c00cc6db-61b8-438e-88e2-358df6eb35f7 | Q2 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | TRISALUS LIFE SCIENCES | 2020 | second_quarter | MED | Medical device development for oncology, drug delivery for oncology | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-15T13:49:35.603000-04:00 | ||
| 2466472 | COMMONWEALTH POLICY SOLUTIONS 6f8884ed-8ed6-4aba-9533-68bd008a5d4c | Q2 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | RARE ACCESS ACTION PROJECT | 2020 | second_quarter | MED | Reimbursement for rare disease patient care | HOUSE OF REPRESENTATIVES,SENATE | 12000 | 0 | 0 | 2020-07-15T13:50:37.253000-04:00 | |
| 2466532 | SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN 502cc758-2b76-46f5-8223-34e38ab63488 | Q2 | SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN | 35068 | SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN | 2020 | second_quarter | MED | Support recognizing construction activities as essential service during pandemic | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-15T14:10:52.473000-04:00 | ||
| 2466652 | NEOGENOMICS LABORATORIES 40d08ab4-3c39-4435-8b69-13d686863344 | Q2 | NEOGENOMICS LABORATORIES | 401105014 | NEOGENOMICS LABORATORIES | 2020 | second_quarter | MED | Verifying Accurate Leading-Edge IVCT Development Act (VALID Act), Draft Legislation | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2020-07-15T14:38:16.733000-04:00 | |
| 2466654 | THE CONAFAY GROUP, LLC f4009bc0-245a-4252-9a8a-01fc9058892e | Q2 | THE CONAFAY GROUP, LLC | 401004840 | HAWAII BIOTECH, INC. | 2020 | second_quarter | MED | Medical countermeasures. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-15T14:39:17.903000-04:00 | |
| 2466884 | GREEN PLAINS INC. 9f9ee02b-d97a-4a21-bcb9-c0a5de251955 | Q2 | GREEN PLAINS INC. | 401104765 | GREEN PLAINS | 2020 | second_quarter | MED | Issues related to the Novel Coronavirus and the disease COVID-19; Issues related to the production of industrial grades of alcohol for inclusion in hand sanitizer; Issues related to the transportation and tax treatment for industrial grades of alcohol for inclusion in hand sanitizer; H.R. 748, the CARES Act; H.R. 6800, the Heroes Act; | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Emergency Management Agency (FEMA),Federal Motor Carrier Safety Administration,Federal Reserve System,Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office | 180000 | 0 | 0 | 2020-07-15T16:13:18.373000-04:00 | |
| 2466931 | THE CONAFAY GROUP, LLC 3e0b4a0d-1ceb-4631-b793-16c0561db9e9 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | ACADIA PHARMACEUTICALS INC. | 2020 | second_quarter | MED | Pharmaceutical research. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-15T16:25:28.317000-04:00 | |
| 2466997 | THE CONAFAY GROUP, LLC ef6d4a13-1b47-4b2f-b092-1b923ce58726 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | EMERGEX VACCINES HOLDING LTD. | 2020 | second_quarter | MED | Influenza and respiratory disease research | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-15T16:55:51.483000-04:00 | |
| 2467002 | POWERS PYLES SUTTER & VERVILLE, P.C. 9575e367-f481-4d6c-94aa-00bd732f21cd | Q2 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | MOSES WEITZMAN HEALTH SYSTEM, INC. | 2020 | second_quarter | MED | Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Financial Services and General Government Appropriations Bill House, Senate Community Health Center Reauthorization Bills Pursuit of grants with federal agencies House, Senate Legislation to to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs and Medical Assistant Training Programs House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Health Provider Consultations (E-Consults) with Related Telemedicine in Health Centers and Rural Health Clinics, H.R. 5190 House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) | Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 10000 | 0 | 0 | 2020-07-15T16:57:53.227000-04:00 | |
| 2467006 | THE CONAFAY GROUP, LLC f4e251a7-170e-4e47-8d69-aaea1a0f74ab | Q2 | THE CONAFAY GROUP, LLC | 401004840 | PREACTIVE TECHNOLOGIES, INC. | 2020 | second_quarter | MED | Traumatic Brain Injury Prevention | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-15T17:00:54.473000-04:00 | ||
| 2467026 | THE CONAFAY GROUP, LLC 63922695-36b7-4dcf-8960-54501e11e251 | 2T | THE CONAFAY GROUP, LLC | 401004840 | PHLOW CORPORATION | 2020 | second_quarter | MED | US pharmaceutical manufacturing | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2020-07-15T17:14:58.880000-04:00 | |
| 2467054 | THE CONAFAY GROUP, LLC f5ed92db-d68f-40ae-9508-d78544f9d6b0 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | CIDARA THERAPEUTICS, INC. | 2020 | second_quarter | MED | Support for research on viral diseases | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-15T17:38:10.347000-04:00 | |
| 2467087 | THE CONAFAY GROUP, LLC 62ee4d96-2c83-40cd-9c3b-4030ede3d586 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | EMERJA, INC. (FORMERLY KNOWN AS WHEEL BIOLOGY, INC.) | 2020 | second_quarter | MED | Seek support for research and development funding | Health & Human Services, Dept of (HHS) | 10000 | 0 | 0 | 2020-07-15T17:59:19.810000-04:00 | |
| 2467098 | POWERS PYLES SUTTER & VERVILLE, P.C. 58f68ea7-2296-4277-a100-7857674add9e | Q2 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | PIH HEALTH FOUNDATION | 2020 | second_quarter | MED | Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Department of Homeland Security Appropriations Bill House, Senate Department of Agriculture Appropriations Bill Pursuit of grants with Federal agencies Telemedicine House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) | Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Communications Commission (FCC),Federal Election Commission (FEC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 30000 | 0 | 0 | 2020-07-15T18:08:21.927000-04:00 | |
| 2467106 | THE CONAFAY GROUP, LLC a4198c42-7633-4277-9bf0-63419f01c7c5 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | LUNGPACER MEDICAL USA, INC | 2020 | second_quarter | MED | Seek support for research and development funding. | Health & Human Services, Dept of (HHS) | 10000 | 0 | 0 | 2020-07-15T18:13:24.120000-04:00 | |
| 2467178 | MEHLMAN CONSULTING, INC. 688177c2-c3e0-47ad-a842-2ed67826c1b3 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | AEGIS SCIENCES CORPORATION | 2020 | second_quarter | MED | H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136; Provisions related to coverage of diagnostic testing | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-15T20:05:46.763000-04:00 | |
| 2467315 | PACE, LLP 3d0f9ac5-26de-48b4-83cf-e1e2526cb8dc | Q2 | PACE, LLP | 30495 | GLADSTONE INSTITUTE | 2020 | second_quarter | MED | Stem cell research for disease and wound treatments COVID response pollcies | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-16T01:16:20.660000-04:00 | ||
| 2467333 | AMERICAN SOCIETY OF ADDICTION MEDICINE f3d543d1-ec57-463e-a469-1a7f5df59aa8 | Q2 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2020 | second_quarter | MED | Advocated for FY2021 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, increase in funding for the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, funding for preventive medicine residency programs, and $8.8 billion for discretionary Health Resources and Services Administration programs. Supported HR 3414 (and prior versions)/ S. 2892 - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration… | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 70000 | 0 | 0 | 2020-07-16T07:16:27.093000-04:00 | |
| 2467693 | MCDERMOTT WILL & SCHULTE LLP 3669f4ab-16bd-433c-a127-4bac57bf1d35 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | MAYO CLINIC | 2020 | second_quarter | MED | Issues impacting academic medical centers. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2020-07-16T10:41:21.857000-04:00 | |
| 2467733 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 374bce5c-19dd-47c7-8809-8c7d2be962de | Q2 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | COLOR HEALTH (FKA COLOR GENOMICS) | 2020 | second_quarter | MED | Lobbying related to healthcare issues. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2020-07-16T10:47:31.067000-04:00 | |
| 2467832 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) a1b897ad-33de-4b96-9978-6da148e16ca8 | Q2 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | INTUITIVE SURGICAL, INC. | 2020 | second_quarter | MED | Lobbying related to health care issues. | SENATE | 20000 | 0 | 0 | 2020-07-16T11:04:57.140000-04:00 | |
| 2467885 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4950397d-04ee-4714-9751-9dba8d93aa2f | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2020 | second_quarter | MED | Research in Endocrinology, Standardization of Hormone Testing Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Special Diabetes Program | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2020-07-16T11:14:10.617000-04:00 | |
| 2467948 | TRAVERE THERAPEUTICS 1348a79c-aa7b-4bee-9edc-6776bdee273b | Q2 | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2020 | second_quarter | MED | Medical research, NIH funding, related appropriations issues; House and Senate Labor HHS Appropriations Act; FY 2021 CDC Appropriations related to newborn screening; H.R. 478, CARES Act; H.R. 6800, HEROES Act; kidney treatment and care issues | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2020-07-16T11:28:25.487000-04:00 | |
| 2468104 | THE CONAFAY GROUP, LLC 65fd3394-32df-4252-8862-40357b1f2d9f | Q2 | THE CONAFAY GROUP, LLC | 401004840 | NABRIVA THERAPEUTICS US, INC. | 2020 | second_quarter | MED | Support for medical countermeasure procurement. | Health & Human Services, Dept of (HHS) | 0 | 0 | 2020-07-16T11:58:10.927000-04:00 | ||
| 2468110 | TWENTY-FIRST CENTURY GROUP, INC. bad03988-a599-44d5-9516-49137d35fe44 | Q2 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) | 2020 | second_quarter | MED | Research and treatment related to suicide prevention for veterans and patients with bipolar depression; COVID-19 research and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-16T11:59:12.140000-04:00 | |
| 2468137 | TWENTY-FIRST CENTURY GROUP, INC. fc3d44d0-d43d-4773-812b-a723e2ec1d1f | Q2 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | CORNERSTONE PHARMACEUTICALS INC. (FORMERLY RAFAEL PHARMACEUTICALS, INC.) | 2020 | second_quarter | MED | Issues related to cancer research and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-16T12:07:24.160000-04:00 | |
| 2468178 | MICHIGAN TECHNOLOGICAL UNIVERSITY d234012b-2a1b-4f9c-b63a-0bd4ceb92b30 | Q2 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 25181 | MICHIGAN TECHNOLOGICAL UNIVERSITY | 2020 | second_quarter | MED | Discussed issues of interest related higher education for the COVID-19 pandemic. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) | 60000 | 0 | 0 | 2020-07-16T12:15:31.803000-04:00 | |
| 2468834 | THE CONAFAY GROUP, LLC 5447bb98-bc4a-4ea8-b5b6-96d77b8b2ee5 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | ATEA PHARMACEUTICALS, INC. | 2020 | second_quarter | MED | Support for medical/disease research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-16T14:15:45.883000-04:00 | |
| 2468881 | THE CONAFAY GROUP, LLC 1f61fa4c-8c44-44ed-807e-9c2d0ba82a71 | Q2 | THE CONAFAY GROUP, LLC | 401004840 | CENTIVAX | 2020 | second_quarter | MED | Support for medical/disease research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-16T14:23:04.677000-04:00 | ||
| 2468928 | THE CONAFAY GROUP, LLC 80b1d3c2-1a86-495e-a54c-adeff13262cc | Q2 | THE CONAFAY GROUP, LLC | 401004840 | PHASEBIO PHARMACEUTICALS, INC | 2020 | second_quarter | MED | Support for medical/disease research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-16T14:30:16.870000-04:00 | |
| 2469305 | CAPITOL COUNSEL LLC a4895781-ce67-4c68-8761-c07d2d69a416 | Q2 | CAPITOL COUNSEL LLC | 313715 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL | 2020 | second_quarter | MED | Monitor health and tax legislation pertaining to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-16T15:37:04.017000-04:00 | |
| 2469318 | FAEGRE DRINKER BIDDLE & REATH LLP 98c5a1e2-3964-4dcd-aafe-5c766e4f7c2c | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2020 | second_quarter | MED | Public Health Programs for Infectious and Tropical Disease; Issues related to NIH grant withdrawal for EcoAlliance. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2020-07-16T15:40:07.300000-04:00 | |
| 2469384 | BURRELL INTERNATIONAL GROUP LLC 7ed6a92d-e92b-467f-8ec2-231221d34af3 | Q2 | BURRELL INTERNATIONAL GROUP LLC | 401103483 | SMALL BIOTECHNOLOGY BUSINESS COALITION | 2020 | second_quarter | MED | VALID Act and Laboratory Diagnostic Testing | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-16T15:50:29.577000-04:00 | ||
| 2470050 | MICHAEL N. MCCARTY LAW OFFICE PLLC fe66608a-7a06-4df3-bd0b-9dea589692e8 | Q2 | MICHAEL N. MCCARTY LAW OFFICE PLLC | 401104300 | AMERICAN MEDICAL TECHNOLOGISTS | 2020 | second_quarter | MED | Appropriations to CDC for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing supply chain issues. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 10000 | 0 | 0 | 2020-07-16T18:48:10.317000-04:00 | |
| 2470251 | WILLIAMS AND JENSEN, PLLC 540876ba-840b-43e2-88db-f99b7a09cbc0 | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | GLOBAL DOWN SYNDROME FOUNDATION | 2020 | second_quarter | MED | Support for down syndrome research funding. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-17T05:52:09.007000-04:00 | |
| 2470311 | WILLIAMS AND JENSEN, PLLC 01513d1f-07dc-4633-a851-77273c1d492a | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | BIOBOT ANALYTICS | 2020 | second_quarter | MED | General education to advance policies that support wastewater surveillance data analytic technology. Policies impacting U.S. address to the Covid-19 pandemic, including implementation of the H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123; H. R . 6201 Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748 CARES Act, Public Law No: 116-136. | Centers For Disease Control & Prevention (CDC),Environmental Protection Agency (EPA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE,White House Office | 30000 | 0 | 0 | 2020-07-17T07:02:20.810000-04:00 | |
| 2470320 | WILLIAMS AND JENSEN, PLLC 954b3d8b-691c-4e11-bee8-e8ef6bff182c | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | SANOFI, U.S. | 2020 | second_quarter | MED | General education about FDA approval policies and NIH research activities. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2020-07-17T07:04:21.767000-04:00 | |
| 2470323 | WILLIAMS AND JENSEN, PLLC 500c1f4b-dbbf-42d8-ad5c-013973dd2ab0 | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | VERTEX PHARMACEUTICALS INCORPORATED | 2020 | second_quarter | MED | General education about FDA approval policies and NIH research activities. | Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 30000 | 0 | 0 | 2020-07-17T07:05:22.480000-04:00 | |
| 2470450 | MANATOS & MANATOS 5dbd4380-29fb-435f-aa77-a88016b963ca | Q2 | MANATOS & MANATOS | 23634 | BARBARA ANN KARMANOS CANCER INSTITUTE | 2020 | second_quarter | MED | PPS-exempt cancer hospitals | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-07-17T09:11:59.170000-04:00 | ||
| 2470533 | TWENTY-FIRST CENTURY GROUP, INC. 071c24a6-0bcd-4729-89fa-e655d52437f3 | Q2 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | GLOBAL ALZHEIMER'S PLATFORM FOUNDATION | 2020 | second_quarter | MED | Inform Congress about the impact of COVID-19 on Alzheimer's clinical trials. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2020-07-17T09:30:16.150000-04:00 | |
| 2470589 | BRACEWELL LLP a3d747b6-3fbf-41c6-9893-e82aa802180b | Q2 | BRACEWELL LLP | 6837 | NATIONAL BRAIN TUMOR SOCIETY | 2020 | second_quarter | MED | work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-17T09:47:29.663000-04:00 | |
| 2470687 | EFB ADVOCACY, LLC fd4050dc-b39b-406b-bd0b-aa3e42204947 | Q2 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2020 | second_quarter | MED | Funding Issues Related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-17T10:05:49.977000-04:00 | |
| 2471079 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 23a68576-3663-49a1-bc71-ec5652fd3966 | Q2 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. | 401104196 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. | 2020 | second_quarter | MED | NIH funding for aging science, tobacco and peer review activities | Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-17T11:16:20.840000-04:00 | |
| 2471175 | FAEGRE DRINKER BIDDLE & REATH LLP cd60bfd0-4101-4284-a6fc-b981da0feed8 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2020 | second_quarter | MED | Issues related to anti-microbial resistance and neglected tropical diseases; CURES 2.0 legislative initiative; Access and affordability of COVID-19 treatments and vaccines; Draft PASTEUR Act legislation. | 10000 | 0 | 0 | 2020-07-17T11:30:42.790000-04:00 | ||
| 2471180 | FAEGRE DRINKER BIDDLE & REATH LLP b5fbeb44-7f88-4022-a2fc-f822d426dfae | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH | 2020 | second_quarter | MED | Cures 2.0.; PASTEUR Act legislative draft. | 10000 | 0 | 0 | 2020-07-17T11:31:44.433000-04:00 | ||
| 2471308 | ALLIANCE FOR RETIRED AMERICANS 7ae74f67-7343-4ea1-b6d4-0b65a7e2dde7 | Q2 | ALLIANCE FOR RETIRED AMERICANS | 67238 | ALLIANCE FOR RETIRED AMERICANS | 2020 | second_quarter | MED | 1. S. 3847, COVID-19 Emergency Manufacturing Act of 2020, entire bill | Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Pension & Welfare Benefits Administration,SENATE,Social Security Administration (SSA),U.S. Trade Representative (USTR) | 80000 | 0 | 0 | 2020-07-17T11:52:19.267000-04:00 | |
| 2471443 | UNIVERSITY OF IOWA c393b01b-01b8-4aac-b7e8-70bf9a997b25 | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2020 | second_quarter | MED | Support for robust funding for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 70000 | 0 | 0 | 2020-07-17T12:07:48.827000-04:00 | |
| 2471554 | DLA PIPER LLP (US) 64962912-bf5b-4a2f-93c7-44cc0cbbb08c | Q2 | DLA PIPER LLP (US) | 76855 | AMERIHEALTH CARITAS | 2020 | second_quarter | MED | Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-17T12:19:19.263000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);